Pharmacokinetics, Efficacy, and Safety of a SARS-CoV-2 Antibody Treatment in Pediatric Participants: An Open-Label Addendum of a Placebo-Controlled, Randomized Phase 2/3 Trial

被引：0
|
作者：
Himanshu P. Upadhyaya
Jenny Y. Chien
Amanda J. Long
Martin S. Bohm
Nicole L. Kallewaard
Lisa F. Macpherson
Dipak R. Patel
Matthew M. Hufford
Constance J. Krull
Jocelyn Y. Ang
Peter Chen
William J. Muller
Jeffrey A. Potts
Timothy Quinn
Mark Williams
机构：
[1] Eli Lilly and Company,
[2] Children’s Hospital of Michigan,undefined
[3] Cedars–Sinai Medical Center,undefined
[4] Ann & Robert H. Lurie Children’s Hospital of Chicago and Northwestern University Feinberg School of Medicine,undefined
[5] Great Lakes Research Group,undefined
[6] Sky Clinical Research Network Group,undefined
[7] Central Michigan University,undefined
来源：
Infectious Diseases and Therapy | 2023年 / 12卷
关键词：
Bamlanivimab; COVID-19; Etesevimab; Monoclonal antibodies; Pediatric; Pharmacokinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1861 / 1873
页数：12
相关论文
共 50 条
  • [1] Pharmacokinetics, Efficacy, and Safety of a SARS-CoV-2 Antibody Treatment in Pediatric Participants: An Open-Label Addendum of a Placebo-Controlled, Randomized Phase 2/3 Trial
    Upadhyaya, Himanshu
    Chien, Jenny Y.
    Long, Amanda J.
    Bohm, Martin
    Kallewaard, Nicole
    Macpherson, Lisa
    Patel, Dipak
    Hufford, Matthew
    Krull, Constance
    Ang, Jocelyn
    Chen, Peter
    Muller, William
    Potts, Jeffrey
    Quinn, Timothy
    Williams, Mark
    [J]. INFECTIOUS DISEASES AND THERAPY, 2023, 12 (07) : 1861 - 1873
  • [2] Efficacy and safety of sofosbuvir in the treatment of SARS-CoV-2: an open label phase II trial
    Alavi-Moghaddam, Mostafa
    Sistanizad, Mohammad
    Haghighi, Mehrdad
    Sabaghian, Tahereh
    Chaboki, Bahare Gholami
    Soroureddin, Zahra
    [J]. FRONTIERS IN EMERGENCY MEDICINE, 2023, 7 (01):
  • [3] Efficacy and safety of Reyanning mixture in patients infected with SARS-CoV-2 Omicron variant: A prospective, open-label, randomized controlled trial
    Xu, Xiangru
    Zhou, Shuang
    Chen, Caiyu
    Li, Jinhua
    Wu, Hongze
    Jin, Guoqiang
    Zhou, Jing
    Wang, Gang
    Cao, Min
    Sun, Ding
    Zhang, Wen
    Peng, Wei
    Pu, Yuting
    Sun, Yuting
    Fang, Bangjiang
    Xu, Jianguang
    [J]. PHYTOMEDICINE, 2023, 108
  • [4] Efficacy and Safety of SARS-CoV-2 Neutralizing Antibody JS']JS016 in Hospitalized Chinese Patients with COVID-19: a Phase 2/3, Multicenter, Randomized, Open-Label, Controlled Trial
    Dong, Run
    Jiang, Li
    Yang, Ting
    Wang, Changsong
    Zhang, Yi
    Chen, Xu
    Xie, Jianfeng
    Guo, Yuanbin
    Weng, Li
    Kang, Yan
    Yu, Kaijiang
    Qiu, Haibo
    Du, Bin
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (03)
  • [5] Adalimumab for nail psoriasis: Efficacy and safety from the open-label extension of a phase-3, randomized, placebo-controlled trial
    Gottlieb, Alice B.
    Elewski, Boni E.
    Okun, Martin M.
    Bagel, Jerry
    Poulin, Yves
    Gu, Yihua
    Williams, David A.
    Valdecantos, Wendell C.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB33 - AB33
  • [6] A randomized, double-blind, placebo-controlled phase 1 and phase 2 clinical trial to evaluate efficacy and safety of a SARS-CoV-2 vaccine SCoK in adults
    Luo, Deyan
    Pan, Hongxing
    He, Peng
    Yang, Xiaolan
    Li, Tao
    Ning, Nianzhi
    Fang, Xin
    Yu, Wenjing
    Wei, Mingwei
    Gao, Hui
    Wang, Xin
    Gu, Hongjing
    Mei, Maodong
    Li, Xinwang
    Zhang, Liangyan
    Li, Deyu
    Gao, Chunrun
    Gao, Jinbang
    Fei, Guoqiang
    Li, Ying
    Yang, Yuguo
    Xu, Yi
    Wei, Wenjin
    Sun, Yansong
    Zhu, Fengcai
    Hu, Zhongyu
    Wang, Hui
    [J]. CLINICAL AND TRANSLATIONAL MEDICINE, 2022, 12 (09):
  • [7] Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial
    Angela R. Branche
    Nadine G. Rouphael
    David J. Diemert
    Ann R. Falsey
    Cecilia Losada
    Lindsey R. Baden
    Sharon E. Frey
    Jennifer A. Whitaker
    Susan J. Little
    Evan J. Anderson
    Emmanuel B. Walter
    Richard M. Novak
    Richard Rupp
    Lisa A. Jackson
    Tara M. Babu
    Angelica C. Kottkamp
    Anne F. Luetkemeyer
    Lilly C. Immergluck
    Rachel M. Presti
    Martín Bäcker
    Patricia L. Winokur
    Siham M. Mahgoub
    Paul A. Goepfert
    Dahlene N. Fusco
    Elissa Malkin
    Jeffrey M. Bethony
    Edward E. Walsh
    Daniel S. Graciaa
    Hady Samaha
    Amy C. Sherman
    Stephen R. Walsh
    Getahun Abate
    Zacharoula Oikonomopoulou
    Hana M. El Sahly
    Thomas C. S. Martin
    Satoshi Kamidani
    Michael J. Smith
    Benjamin G. Ladner
    Laura Porterfield
    Maya Dunstan
    Anna Wald
    Tamia Davis
    Robert L. Atmar
    Mark J. Mulligan
    Kirsten E. Lyke
    Christine M. Posavad
    Megan A. Meagher
    David S. Stephens
    Kathleen M. Neuzil
    Kuleni Abebe
    [J]. Nature Medicine, 2023, 29 : 2334 - 2346
  • [8] Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial
    Branche, Angela R.
    Rouphael, Nadine G.
    Diemert, David J.
    Falsey, Ann R.
    Losada, Cecilia
    Baden, Lindsey R.
    Frey, Sharon E.
    Whitaker, Jennifer A.
    Little, Susan J.
    Anderson, Evan J.
    Walter, Emmanuel B.
    Novak, Richard M.
    Rupp, Richard
    Jackson, Lisa A.
    Babu, Tara M.
    Kottkamp, Angelica C.
    Luetkemeyer, Anne F.
    Immergluck, Lilly C.
    Presti, Rachel M.
    Baecker, Martin
    Winokur, Patricia L.
    Mahgoub, Siham M.
    Goepfert, Paul A.
    Fusco, Dahlene N.
    Malkin, Elissa
    Bethony, Jeffrey M.
    Walsh, Edward E.
    Graciaa, Daniel S.
    Samaha, Hady
    Sherman, Amy C.
    Walsh, Stephen R.
    Abate, Getahun
    Oikonomopoulou, Zacharoula
    El Sahly, Hana M.
    Martin, Thomas C. S.
    Kamidani, Satoshi
    Smith, Michael J.
    Ladner, Benjamin G.
    Porterfield, Laura
    Dunstan, Maya
    Wald, Anna
    Davis, Tamia
    Atmar, Robert L.
    Mulligan, Mark J.
    Lyke, Kirsten E.
    Posavad, Christine M.
    Meagher, Megan A.
    Stephens, David S.
    Neuzil, Kathleen M.
    Abebe, Kuleni
    [J]. NATURE MEDICINE, 2023, 29 (09) : 2334 - +
  • [9] An open-label randomized controlled trial of leflunomide in patients with acute SARS-CoV-2 omicron variant infection
    Pan, Zhou
    Wan, Zhihui
    Wang, Yixuan
    Zha, Shiqian
    Zhang, Jingyi
    Chen, Hao
    Hu, Ke
    [J]. FRONTIERS IN MEDICINE, 2023, 10
  • [10] The safety, immunogenicity, and efficacy of heterologous boosting with a SARS-CoV-2 mRNA vaccine (SYS6006) in Chinese participants aged 18 years or more: a randomized, open-label, active-controlled phase 3 trial
    Zhou, Chunhua
    Qiu, Yuanzheng
    Wang, Jianxin
    Zhong, Xiang
    Zhu, Xiufang
    Huang, Xiaojing
    Yang, Lan
    Ji, Qiaolei
    Zhou, Feifei
    Wu, Shunquan
    Yang, Mengjie
    Zhang, Jing
    Liu, Kaili
    Ji, Li
    Yang, Hanyu
    Li, Chunlei
    Zhao, Yuanyuan
    [J]. EMERGING MICROBES & INFECTIONS, 2024, 13 (01)
12345